amantadine and benserazide

amantadine has been researched along with benserazide in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-199016 (69.57)18.7374
1990's1 (4.35)18.2507
2000's1 (4.35)29.6817
2010's4 (17.39)24.3611
2020's1 (4.35)2.80

Authors

AuthorsStudies
Agnoli, A; Carolei, A; Casacchia, M; Fazio, C; Zamponi, A1
Dinnendahl, V; Gumulka, SW; Peters, HD; Schönhöfer, PS1
Barbeau, A; Butterworth, RF; Campanella, G; Yamada, K1
Lazarova, MB; Roussinov, KS1
Clemens, R1
Lapin, IP; Patkina, NA1
Fernandez, FC; Lindsley, DF; Ranf, SK; Wyrwicka, W1
Przewlocki, R1
Birkmayer, W1
Lieberman, AN1
Gressier, H; Malecot, E; Poignant, JC1
Candelise, L; Faglioni, P; Spinnler, H; Vignolo, LA1
Masi, G; Megna, GF; Puca, FM; Specchio, LM1
Cashin, CH; Sutton, S1
van der Zee, HJ; van Nieuwenhuizen, O; Zweije-Hofman, IL1
Ando, K1
Hagell, P; Odin, P; Vinge, E1
Arai, A; Kannari, K; Maeda, T; Matsunaga, M; Shen, H; Suda, T1
Bozi, M; Christodoulou, C; Douzenis, A; Gasparinatos, G; Stamboulis, E; Stefanis, C; Stefanis, L; Stefanis, N1
Auguet, M; Chabrier, PE; Charnet, C; Cornet, S; Roubert, V; Spinnewyn, B1
Ivanova, EA; Kapitsa, IG; Kokshenev, II; Nepoklonov, AV; Val'dman, EA; Voronina, TA1
Nakagawasai, O; Nemoto, W; Sato, S; Tadano, T; Tan-no, K; Taniguchi, R; Yamadera, F; Yaoita, F1
Furukawa, T; Kinoshita, I; Kon, T; Murakami, Y; Nakamura, T; Nishijima, H; Suzuki, C; Tomiyama, M1

Reviews

2 review(s) available for amantadine and benserazide

ArticleYear
[Antiparkinsonian drugs (author's transl)].
    No to shinkei = Brain and nerve, 1980, Volume: 32, Issue:8

    Topics: Amantadine; Antiparkinson Agents; Benserazide; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Receptors, Dopamine

1980
Pregnancy in Parkinson's disease: a review of the literature and a case report.
    Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:1

    Topics: Abnormalities, Drug-Induced; Adjuvants, Pharmaceutic; Adult; Amantadine; Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Dopamine Agents; Enzyme Inhibitors; Female; Humans; Levodopa; Mice; Parkinson Disease; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Rabbits; Rats; Selegiline

1998

Trials

2 trial(s) available for amantadine and benserazide

ArticleYear
Letter: Treatment of Huntington's chorea.
    The New England journal of medicine, 1973, Nov-29, Volume: 289, Issue:22

    Topics: Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Clinical Trials as Topic; Diazepam; Dihydroxyphenylalanine; Drug Therapy, Combination; Haloperidol; Humans; Huntington Disease; Hydrazines; Reserpine

1973
Anti-parkinson drugs in the Batten-Spielmeyer-Vogt syndrome; a pilot trial.
    Clinical neurology and neurosurgery, 1982, Volume: 84, Issue:2

    Topics: Adolescent; Adult; Amantadine; Antiparkinson Agents; Benserazide; Drug Combinations; Humans; Levodopa; Lipidoses; Psychoses, Substance-Induced; Syndrome

1982

Other Studies

19 other study(ies) available for amantadine and benserazide

ArticleYear
[Therapy of Parkinson's disease. Practical criteria of treatment].
    Recenti progressi in medicina, 1976, Volume: 60, Issue:5

    Topics: Amantadine; Antiparkinson Agents; Benserazide; Carbidopa; Cyproheptadine; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piribedil; Pizotyline; Propranolol

1976
Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo.
    Naunyn-Schmiedeberg's archives of pharmacology, 1976, Volume: 293, Issue:1

    Topics: Amantadine; Amphetamine; Animals; Apomorphine; Benserazide; Brain; Cerebellum; Cyclic AMP; Cyclic GMP; Dopamine; Dose-Response Relationship, Drug; Humans; Isoquinolines; Levodopa; Male; Mice; Nucleotides, Cyclic; Stereotyped Behavior

1976
Uptake and efflux of 14-C-dopamine in platelets: evidence for a generalized defect in Parkinson's disease.
    Neurology, 1975, Volume: 25, Issue:1

    Topics: Adult; Aged; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Blood Platelets; Carbon Radioisotopes; Depression, Chemical; Dopamine; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Female; Histamine H1 Antagonists; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Time Factors; Trihexyphenidyl

1975
On certain effects of dopaminergic agents in pentylenetetrazol convulsions.
    Acta physiologica et pharmacologica Bulgarica, 1978, Volume: 4, Issue:3

    Topics: Amantadine; Animals; Benserazide; Dextroamphetamine; Dopamine; Drug Interactions; Haloperidol; Levodopa; Male; Mice; Pentylenetetrazole; Rats; Seizures

1978
[Therapy of Parkinson's syndrome].
    Deutsche medizinische Wochenschrift (1946), 1976, Mar-12, Volume: 101, Issue:11

    Topics: Amantadine; Benserazide; Carbidopa; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Reserpine; Stereotaxic Techniques

1976
Effects of catecholaminergic drugs on systems of reward and punishment in experiments on cats.
    Pharmacology, biochemistry, and behavior, 1976, Volume: 5, Issue:3

    Topics: Amantadine; Amphetamine; Animals; Behavior, Animal; Benserazide; Catecholamines; Cats; Disulfiram; Electric Stimulation; Electrodes, Implanted; Levodopa; Male; Punishment; Reward

1976
Effects of anti-parkinsonian drugs on the motor activity and EEG of cats with subthalamic lesions.
    Experimental neurology, 1975, Volume: 47, Issue:3

    Topics: Amantadine; Animals; Antiparkinson Agents; Attention; Behavior, Animal; Benserazide; Cats; Cerebral Cortex; Cortical Synchronization; Dextroamphetamine; Diencephalon; Electroencephalography; Functional Laterality; Levodopa; Motor Activity; Neural Pathways; Reticular Formation

1975
The effects of apomorphine and 1,3-dimethyl-5-aminoadamantane (DMAA) on ponto-geniculo-occipital (PGO) waves in cats.
    Polish journal of pharmacology and pharmacy, 1975, Volume: 27, Issue:Suppl

    Topics: Amantadine; Animals; Apomorphine; Benserazide; Cats; Dopamine; Electroencephalography; Geniculate Bodies; Memantine; Occipital Lobe; Serotonin

1975
[Therapeutic strategies and tactics in parkinsonism].
    Wiener medizinische Wochenschrift (1946), 1986, Aug-31, Volume: 136, Issue:15-16

    Topics: Amantadine; Antidepressive Agents; Antiparkinson Agents; Benserazide; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Motor Skills; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders

1986
Parkinson's disease.
    Comprehensive therapy, 1986, Volume: 12, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Benserazide; Carbidopa; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Rats

1986
Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the rat.
    European journal of pharmacology, 1974, Volume: 29, Issue:1

    Topics: Amantadine; Analgesics, Opioid; Animals; Antiparkinson Agents; Apomorphine; Atropine; Benserazide; Benzyl Compounds; Catatonia; Dextroamphetamine; Dextromoramide; Dihydroxyphenylalanine; Dioxoles; Dose-Response Relationship, Drug; Humans; Male; Morphine; Piperazines; Pyrimidines; Rats; Time Factors; Trihexyphenidyl

1974
[Psychological changes in parkinsonian patients during L-DOPA, amantidine, and L-DOPA + IDC treatment (author's transl)].
    Rivista di patologia nervosa e mentale, 1974, Volume: 95, Issue:5

    Topics: Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Drug Therapy, Combination; Humans; Hydrazines; Levodopa; Mental Processes; Parkinson Disease; Psychological Tests

1974
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
    British journal of pharmacology, 1973, Volume: 47, Issue:3

    Topics: Amantadine; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Benztropine; Brain Chemistry; Catalepsy; Dextroamphetamine; Dihydroxyphenylalanine; Humans; Hydroxydopamines; Methylphenidate; Methyltyrosines; Rats; Reserpine; Scopolamine

1973
Amantadine increases L-DOPA-derived extracellular dopamine in the striatum of 6-hydroxydopamine-lesioned rats.
    Brain research, 2003, May-16, Volume: 972, Issue:1-2

    Topics: Adrenergic Agents; Amantadine; Analysis of Variance; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benserazide; Corpus Striatum; Dialysis; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Extracellular Space; Levodopa; Male; Oxidopamine; Rats; Rats, Wistar; Time Factors

2003
Isolated delusional syndrome in Parkinson's Disease.
    Parkinsonism & related disorders, 2010, Volume: 16, Issue:8

    Topics: Aged; Amantadine; Antiparkinson Agents; Benserazide; Benzothiazoles; Catechols; Clonazepam; Female; Humans; Indans; Indoles; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Pramipexole; Schizophrenia, Paranoid; Syndrome

2010
An improved model to investigate the efficacy of antidyskinetic agents in hemiparkinsonian rats.
    Fundamental & clinical pharmacology, 2011, Volume: 25, Issue:5

    Topics: Adenosine A2 Receptor Antagonists; Amantadine; Animals; Antiparkinson Agents; Behavior, Animal; Benserazide; Biological Assay; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agents; Drug Administration Schedule; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Placebos; Purines; Random Allocation; Rats; Reproducibility of Results; Rotation; Sample Size; Single-Blind Method; Sympatholytics

2011
[Comparative study of amantadine and hemantane effects on development of levodopa-induced dyskinesia in rat model of parkinsonian syndrome].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:7

    Topics: Adamantane; Amantadine; Animals; Behavior, Animal; Benserazide; Disease Models, Animal; Dyskinesia, Drug-Induced; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Substantia Nigra

2011
Combined low calcium and lack magnesium is a risk factor for motor deficit in mice.
    Bioscience, biotechnology, and biochemistry, 2013, Volume: 77, Issue:2

    Topics: Amantadine; Animals; Antiparkinson Agents; Benserazide; Bromocriptine; Calcium; Catalepsy; Dopamine Agonists; Food, Formulated; Levodopa; Magnesium; Magnesium Deficiency; Male; Mice; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Substantia Nigra; Tyrosine 3-Monooxygenase

2013
Altered amantadine effects after repetitive treatment for l-dopa-induced involuntary movements in a rat model of Parkinson's disease.
    Neuroscience letters, 2023, 05-29, Volume: 806

    Topics: Amantadine; Animals; Antiparkinson Agents; Benserazide; Disease Models, Animal; Dyskinesia, Drug-Induced; Levodopa; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley

2023